On May 18, 2017, ProPhase Labs, Inc. (the Company) held its Annual Meeting of Stockholders (the

Annual Meeting

). As at the record date of April 18, 2017, the Company had 17,080,776 shares of common stock, par value $0.0005 per share (the Common Stock), outstanding and entitled to vote at the Annual Meeting. The following is a listing of the votes cast for or withheld, and the number of broker non-votes, with respect to each nominee for director and a listing of the votes cast for and against, as well as abstentions and broker-non votes, with respect to the vote to ratify the appointment of EisnerAmper LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2017. At the Annual Meeting, the Companys stockholders (i) electe d each nominee as a director to serve as a director until the next annual meeting of stockholders and until his successor is duly elected and qualified and (ii) ratified the appointment of EisnerAmper LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2017.

1.

Directors Information:

Number of Shares

Director

For

Withheld

Broker Non-Votes

1. Ted Karkus

9,325,971

2,626,779

3,673,436

2. Jason Barr

9,484,064

2,468,686

3,673,436

3. Mark Burnett

9,326,011

2.626,739

3,673,436

4. Louis Gleckel, MD

9,285,671

2,667,079

3,673,436

5. Mark Leventhal

9,326,471

2,626,279

3,673,436

2.

To ratify the appointment of EisnerAmper LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2017:

For

Against

Abstentions

Broker Non-Votes

13,157,801

98,059

2,370,326

-

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ProPhase Labs, Inc.

By:

/s/ Robert V. Cuddihy, Jr.

Robert V. Cuddihy, Jr.

Chief Financial Officer

(Principal Accounting and Financial Officer

Date: May 19, 2017

makes a similar move, sign up!

Other recent filings from the company include the following:

Tender offer statement by Issuer - Nov. 20, 2017
Prophase Labs Reports Financial Results - Nov. 13, 2017
ProPhase Labs Just Filed Its Quarterly Report: Note 8 – Earnings (... - Nov. 13, 2017

Auto Refresh

Feedback